Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment

Journal of Environmental Management

Volumn 133, Issue , 2014, Pages 378-387

  Zenker, Armin ^a   Cicero, Maria Rita ^b   Prestinaci, Francesca ^b   Bottoni, Paola ^b   Carere, Mario ^b  

^a UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Aquatic ecosystems; Bioaccumulation; Biomagnification; Human health; Pharmaceuticals

Indexed keywords

AGRICULTURE; AQUATIC ORGANISMS; BIOACCUMULATION; BIOCHEMISTRY; EFFLUENTS; HEALTH RISKS; RECLAMATION; RISK ASSESSMENT; SEDIMENTS; SEWAGE PUMPING PLANTS; SURFACE WATERS; TOXICITY; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

AQUATIC ENVIRONMENTS; BIOMAGNIFICATION; CHEMICO-PHYSICAL PROPERTIES; EMERGING CONTAMINANT; HUMAN DISEASE; HUMAN HEALTH; LOW CONCENTRATIONS; MODE OF ACTION; TRANSFORMATION PRODUCTS; WASTE WATER TREATMENT PLANTS;

AQUATIC ECOSYSTEMS;

SURFACE WATER;

ANALYTICAL METHOD; AQUATIC ENVIRONMENT; BIOACCUMULATION; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; HEALTH RISK; SURFACE WATER; WATER COLUMN; WATER POLLUTION;

ANALYTIC METHOD; ANIMAL DISEASE; AQUACULTURE; AQUATIC ENVIRONMENT; AQUATIC SPECIES; BIOACCUMULATION; BIOAVAILABILITY; BIOLOGICAL ACTIVITY; BIOMAGNIFICATION; BIOSOLID; BIOTA; DEVELOPED COUNTRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; HEALTH HAZARD; LIVESTOCK; NONHUMAN; PHARMACOLOGICAL PARAMETERS; REVIEW; RISK ASSESSMENT; SEDIMENT; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION;

AQUATIC ECOSYSTEMS; BIOACCUMULATION; BIOMAGNIFICATION; HUMAN HEALTH; PHARMACEUTICALS;

ENVIRONMENTAL MONITORING; PHARMACEUTICAL PREPARATIONS; WATER POLLUTANTS, CHEMICAL;

EID: 84892500005     PISSN: 03014797     EISSN: 10958630     Source Type: Journal    
DOI: 10.1016/j.jenvman.2013.12.017     Document Type: Review

References (125)

1. Al-Ansari A.M., Saleem A., Kimpe L.E., Sherry J.P., McMaster M.E., Trudeau V.L., Blais J.M. Bioaccumulation of the pharmaceutical 17a-ethinylestradiol in shorthead redhorse suckers (Moxostoma macrolepidotum) from the St. Clair River, Canada. Environ. Pollut. 2010, 158:2566-2571.
2. Andreozzi R., Marotta R., Paxéus N. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
3. Avdeef A., Box K.J., Comer J.E.A., Hibbert C., Tam K.Y. pH-metric logP 10. Determination of liposomal membrane-water partitioning coefficients of ionizable drugs. Pharm. Res. 1998, 15(2):209-215.
4. Baran W., Ewa Adamek E., Ziemianska J., Sobczak A. Effects of the presence of sulfonamides in the environment and their influence on human health. J.Hazard. Mater. 2011, 196:1-15.
5. Barcelo D. Pharmaceutical-residue analysis. Trends Anal. Chem. 2007, 26(6):454-455.
6. Baronti C., Curini R., D'Ascenzo G., Di Corcia A., Gentili A., Samperi R. Monitoring natural and synthetic estrogens at activated sludge sewage teratment plants and in receiving water. Environ. Sci. Technol. 2000, 34:5059-5066.
7. Borgmann U., Bennie D.T., Ball A.L., Palabrica V. Effect of a mixture of seven pharmaceuticals on Hyalella azteca over multiple generations. Chemosphere 2007, 66:1278-1283.
8. Bottoni P., Caroli S., Barra Caracciolo A. Pharmaceuticals as priority water contaminants. Toxicol. Environ. Chem. 2010, 92(3):549-565.
9. Bound J.P., Voulvoulis N. Pharmaceuticals in the aquatic environments-a comparison of risk assessment strategies. Chemosphere 2004, 56(11):1143-1155.
10. Brent R.L. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Birth Defects Res. (Part B) 2004, 71:303-320.
11. Bringolf R.B., Heltsley R.M., Newton T.J., Eads C.B., Fraley S.J., Shea D., Cope W.G. Environmental occurrence and reproductive effects of the pharmaceutical fluoxetine in native freshwater mussels. Environ. Toxicol. Chem. 2010, 29(6):1311-1318.
12. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
13. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ. Toxicol. Chem. 2005, 24:464-469.
14. Brown J.N., Paxéus N., Förlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Chem. 2007, 24(3):267-274.
15. Brozinski J.M., Lahti M., Oikari A., Kronberg L. Detection of naproxen and its metabolites in fish bile following intraperitoneal and aqueous exposure. Environ. Sci. Pollut. Res. 2011, 18:811-818.
16. Bruggeman W.A., Opperhuizen A., Wijbenga A. Bioaccumulation of super-lipophilic chemicals in fish. Toxicol. Environ. Chem. 1984, 7:173-189.
17. Buchberger W. Current approaches to trace analysis of pharmaceuticals and personal care products in the environment. J.Chromatogr. A 2011, 1218(4):603-618.
18. Buerge I.J., Buser H.R., Poiger T., Müller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and Ifosfamide in wastewater and surface waters. Environ. Sci. Technol. 2006, 40(23):7242-7250.
19. Buser H.R., Müller M.D., Theobald N. Occurrence of the pharmaceutical drug clofibric acid and the herbicide mecoprop in various Swiss lakes and in the North Sea. Environ. Sci. Technol. 1998, 32(1):188-192.
20. Buser H.R., Poiger T., Müller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ. Sci. Technol. 1998, 32(22):3449-3456.
21. Buser H.R., Poiger T., Müller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ. Sci. Technol. 1999, 33(15):2529-2535.
22. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 77:1257-1274.
23. Carere M., Dulio V., Hanke G., Polesello S. Guidance for sediment and biota monitoring under the common implementation strategy for the water framework directive. TRAC. "Trends Anal. Chem." 2012, 36:15-24.
24. Chair M., Nelis H.J., Leger P., Sorgeloos P., De Leenheer A.P. Accumulation of trimethoprim, sulfamethoxazole, and n-acetylsulfamethoxazole in fish and shrimp fed medicated Artemia franciscana. Antimicrob. Agents Chemother. 1996, 40(7):1649-1652.
25. Chenxi W., Spongberg A.L., Witter J.D. Determination of the persistence of pharmaceuticals in biosolids using liquid-chromatography tandem mass spectrometry. Chemosphere 2008, 73:511-518.
26. Choi K., Kim Y., Park J., Park C.K., Kim M.Y., Kim H.S., Kim P. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci. Total Environ. 2008, 405:120-128.
27. Christensen F.M. Pharmaceuticals in the environment - a human risk?. Regul. Toxicol. Pharmacol. 1998, 28(3):212-221.
28. Chu S., Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry. J.Chromatogr. A 2007, 1163:112-118.
29. Contardo-Jara V., Pflugmacher S., Nützmann G., Kloas W., Wiegand C. The b-receptor blocker metoprolol alters detoxification processes in the non-target organism Dreissena polymorpha. Environ. Pollut. 2010, 158:2059-2066.
30. Daughton Ch.G., Ruhoy I.S. Knowledge and Need Assessment on Pharmaceutical Products in Environmental Waters 2008, KNAPPE, Available from:. http://www.knappe-eu.org.
31. Diaz-Cruz M.S., Lopez de Alda M.J., Barcelo D. Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends Anal. Chem. 2003, 22(6):340-351.
32. Edwards M., Topp E., Metcalfe C.D., Li H., Gottschall N., Bolton P., Curnoe W., Payne M., Beck A., Kleywegt S., Lapen D.R. Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field. Sci. Total Environ. 2009, 407:4220-4230.
33. Eggen T., Lillo C. Antidiabetic II drug metformin in plants: uptake and translocation to edible parts of cereals, oily seeds, beans, tomato, squash, carrots and potatoes. J.Agric. Food Chem. 2012, 60(28):6929-6935.
34. Erickson R.J., Mckim J.M., Lien G.J., Hoffman A.D., Batterman S.L. Uptake and elimination of ionizable organic chemicals at fish gills: II. Observed and predicted effects of pH, alkalinity, and chemical properties. Environ. Toxicol. Chem. 2006, 25:1522-1532.
35. European Commission WFD-CIS Guidance Document No. 27 Technical Guidance for Deriving Environmental Quality Standards 2011, 204. Office for Official Publications of the European Communities, Luxembourg. http://www.forum.europa.eu.int.
36. European Medicines Agency (EMEA) Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use (EMEA/CHMP/SWP/4447/00 June 2006.
37. European Union Directive 2013/39 of the European Parliament and of the Council of 12 August 2013 Amending Directives 2000/60/EC and 2008/105/EC as Regards Priority Substances in the Field of Water Policy 2013, Official Journal of the European Union, L 226/1.
38. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and Diclofenac. Ecotoxicol. Environ. Saf. 2003, 55:359-370.
39. Ferreira da Silva B., Jelic A., López-Serna R., Mozeto A.A., Petrovic M., Barceló D. Occurrence and distribution of pharmaceuticals in surface water, suspended solids and sediments of the Ebro river basin, Spain. Chemosphere 2011, 85(8):1331-1339.
40. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ. Sci. Technol 2010, 44(7):2661-2666.
41. Fong P.P., Molnar N. Norfluoxetine induces spawning and parturition in estuarine and freshwater bivalves. Bull. Environ. Contam. Toxicol. 2008, 81:535-538.
42. Garcia S.N., Foster M., Constantine L., Hugget D.B. Field and Laboratory fish tissue accumulation of the anti-convulsant drug carbamazepine. Ecotoxicol. Environ. saf. 2012, 84:207-211.
43. Gobas F.A.P.C., de Wolf W., Burkhard L.P., Verbruggen E., Plotzke K. Revisiting bioaccumulation criteria for POPs and PBT assessments. Integr. Environ. Assess. Manag. 2009, 5(4):624-637.
44. Gomez C.F., Constantine L., Huggett D.B. The influence of gill and liver metabolism on the predicted bioconcentration of three pharmaceuticals in fish. Chemosphere 2010, 81:1189-1195.
45. Gray J.S. Biomagnification in marine systems: the perspective of an ecologist. Mar. Pollut. Bull. 2002, 45:46-52.
46. Gunnarsson L., Jauhiainen A., Kristianssn E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 2008, 42:5807-5813.
47. Hansch C., Leo A., Hoekman D. Exploring QSAR - Hydrophobic, Electronic, and Steric Constants 1995, American Chemical Society, Washington, DC.
48. Heberer T. Occurrence, fate and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131(1-2):5-17.
49. Heltsley R.M., Cope W.G., Bringolf R.B., Eads C.B., Shea D. Prozac elicits spawning in native freshwater mussels. 232nd Annual Meeting of the American Chemical Society, San Francisco, CA, September 10-14, 2006 2006.
50. Herklotz P.A., Gurung P., Vanden Heuvel B., Kinney C.A. Uptake of human pharmaceuticals by plants grown under hydroponic conditions. Chemosphere 2010, 78:1416-1421.
51. Highman B., Greenman D.L., Noorwell M.J., Farmer, Shellenberger T.E. Neoplastic and preneoplastic lesions induced in femal C3H mice by diets containing diethylstilbestrol or 17beta-estradiol. J.Environ. Pathol. Toxicol. 1980, 4:81-95.
52. Hoeger B., Köllner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 2005, 75:53-64.
53. Hou X., Shen J., Zhang S., Jiang H., Coats J.R. Bioconcentration and elimination of sulfamethazine and its main metabolite in sturgeon (Acipenser schrenkii). J.Agric. Food Chem. 2003, 51(26):7725-7729.
54. Howard P.H., Muir D.C.G. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals. Environ. Sci. Technol. 2011, 45:6938-6946.
55. Huerta B., Jakimsk A., Gros M., Rodríguez-Mozaz S., Barceló D. Analysis of multi-class pharmaceuticals in fish tissues by ultra-high-performance liquid chromatography tandem mass spectrometry. J.Chromatogr. A 2013, 1288:63-72.
56. IARC Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2007, vol. 91. World Health Organization, International Agency for Research on Cancer, Lyon, France, 528.
57. Ingram T., Richter U., Mehling T., Smirnova I. Modelling of pH dependent n-octanol/water partition coefficients of ionisable pharmaceuticals. Fluid Phase Equilib. 2011, 305:197-203.
58. Jones O.A.H., Voulvoulis N., Lester J.N. Human pharmaceuticals in the aquatic environment: a review. Environ. Technol. 2001, 22:1383-1395.
59. Jones O.A.H., Voulvoulis N., Lester J.N. Potential Impact of pharmaceuticals on environmental health. Bull. World Health Organ. 2003, 81(10):768-769.
60. Kahle M., Stamm C. Sorption of veterinary antimicrobial sulfathiazole to organic materials of different origin. Environ. Sci. Technol. 2007, 41:132-138.
61. Kallio J.M., Lahti M., Oikari A., Kronberg L. Metabolites of the aquatic pollutant diclofenac in fish bile. Environ. Sci. Technol 2010, 44:7213-7219.
62. Karnjanapiboonwong A., Chase D.A., Cañas J.E., Jackson W.A., Maul J.D., Morse A.N., Anderson T.A. Uptake of 17α-ethynylestradiol and triclosan in pinto bean, Phaseolus vulgaris. Ecotoxicol. Environ. Saf. 2011, 74(5):1336-1342.
63. Kim S.C., Carlson K. Occurrence of ionophore antibiotics in water and sediments of a mixed-landscape watershed. Water Res. 2006, 40:2549-2560.
64. Kim Y., Choi K., Jung J., Park S., Kim P.G., Park J. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ. Int. 2007, 33:370-375.
65. Kinney C.A., Furlong E.T., Kolpin D.W., Burkhardt M.R., Zaugg S.D., Werner S.L., Bossio J.P., Benotti M.J. Bioaccumulation of pharmaceuticals and other anthropogenic waste indicators in earthworms from agricultural soil amended with biosolid or swine manure. Environ. Sci. Technol. 2008, 42(6):1863-1870.
66. Klarschlammverordnung (AbfKlärV), 1992. http://www.gesetze-iminternet.de/abfkl_rv_1992/index.html.
67. Kosjek T., Heath E., Petrovic M., Barcelo D. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. Trends Anal. Chem. 2007, 26(11):1076-1085.
68. Kumar A., Xagoraraki I. Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: a proposed ranking system. Sci. Total Environ. 2010, 408:5972-5989.
69. Kümmerer K. Antibiotics in the aquatic environment - a review - part I. Chemosphere 2009, 75:417-434.
70. Kümmerer K. Pharmaceuticals in the Environment. Annu. Rev. Environ. Resour. 2010, 35:57-75.
71. Lacey C., McMahon G., Bones J., Barron L., Morrissey A., Tobin J.M. An LC-MS method for the determination of pharmaceutical compounds in wastewater treatment plant influent and effluent samples. Talanta 2008, 75:1089-1097.
72. Laganà A., Bacaloni A., De Leva I., Faberi A., Fago G., Marino A. Analytical methodologies for determining the occurrence of endocrine disrupting chemicals in sewage treatment plants and natural waters. Anal. Chim. Acta 2004, 501(1):79-88.
73. Lahti M., Brozinski J.M., Jylhä A., Kronberg L., Oikari A. Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ. Toxicol. 2011, 30(6):1403-1411.
74. Lajeunesse A., Gagnon C., Gagné F., Louis S., Čejka P., Sauvé S. Distribution of antidepressants and their metabolites in brook trout exposed to municipal wastewaters before and after ozone treatment - evidence of biological effects. Chemosphere 2011, 83(4):564-571.
75. Länge R., Hutchinson T.H., Croudace C.P., Siegmund F., Schweinfurth H., Hampe P., Panter G.H., Sumpter J.P. Effects of the synthetic estrogen 17α-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2001, 20:1216-1227.
76. Lange A., Paull G.C., Coe T.S., Katsu Y., Urushitani H., Iguchi T., Tyler C.R. Sexual reprogramming and estrogenic sensitization in wild fish exposed to ethinylestradiol. Environ. Sci. Technol. 2009, 43:1219-1225.
77. Langford K., Thomas K.V. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment. J.Environ. Monit. 2011, 13:416-421.
78. Lapen D.R., Topp E., Metcalfe C.D., Edwards H.Li.M., Gottschall N., Bolton P., Curnoe W., Payne M., Beck A. Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids. Sci. Total Environ. 2008, 399:50-65.
79. Larsson D.G.J., de Pedro C., Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J.Hazard. Mater. 2007, 148:751-755.
80. Macherius A., Eggen T., Lorenz W., Moeder M., Ondruschka J., Reemtsma T. Metabolization of the bacteriostatic agent triclosan in edible plants and its consequences for plant uptake assessment. Environ. Sci. Technol. 2012, 46:10797-10804.
81. Maskaoui K., Zhou J.L. Colloids as a sink for certain pharmaceuticals in the aquatic environment. Environ. Sci. Pollut. Res. 2010, 17:898-907.
82. Meador J. Rationale and procedures for using the tissue-residue approach for toxicity assessment and determination of tissue, water, and sediment quality guidelines for aquatic organisms. Hum. Ecol. Risk Assess. 2006, 12:1018-1073.
83. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ Sci. Technol. 2010, 44(6):2176-2182.
84. Meredith-Williams M., Carter L.J., Fussell R., Raffaelli D., Ashauer R., Boxall A.B. Uptake and depuration of pharmaceuticals in aquatic invertebrates. Environ. Pollut. 2012, 165:250-258.
85. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29(1):79-89.
86. Mimeault C., Woodhouse A.J., Miaob X.S., Metcalfe C.D., Moon T.W., Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat. Toxicol. 2005, 73:44-54.
87. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., Tatarazako N. The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 2008, 70(5):865-873.
88. Nallani G.P., Paulos P.M., Constantine L.A., Venables B.J., Huggett D.B. Bioconcentration of ibuprofen in fathead minnow (Pimephales promelas) and channel catfish (Ictalurus punctatus). Chemosphere 2011, 84:1371-1377.
89. OECD OECD GUIDELINES FOR THE TESTING OF CHEMICALS Bioaccumulation in Sediment-dwelling Benthic Oligochaetes 2008, 315. OECD Guideline.
90. Paterson G., Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130.
91. Pedersen J.A., Soliman M., Suffet I.H. Human pharmaceuticals, hormones, and personal care products ingredients in runoff from agricultural fields irrigated with treated waste water. J.Agric. Food Chem. 2005, 53:1625-1632.
92. Pfizer Sertraline Hydrochloride Film Coated Tablets 2006, Material Safety Data Sheet. http://www.pfizer.com/files/products/material_safety_data/268.pdf.
93. Poiger T., Buser H.R., Müller M.D. Photodegradation of the pharmaceutical drug diclofenac in a lake: pathway, field measurements, and mathematical modeling. Environ. Toxicol. Chem. 2001, 20(2):256-263.
94. Pontolillo J., Eganhouse R.P. The Search for Reliable Aqueous Solubility (Sw) and Octanol-water Partition Coefficient (Kow) Data for Hydrophobic Organic Compounds: DDT and DDE as a Case Study 2001, http://pubs.water.usgs.gov/wri01-4201/.
95. Ramirez A.J., Mottaleb M.A., Brooks B.W., Chambliss C.K. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry. Anal. Chem. 2007, 79:3155-3163.
96. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., Wathen J.B., Snyder B.D., Pitt J.L., Perez-Hurtado P., Dobbins L.L., Brooks B.W., Chambliss C.K. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ. Toxicol. Chem. 2009, 28(12):2587-2597.
97. Redshaw C.H., Cooke M.P., Talbot H.M., McGrath S., Rowland S.J. Low biodegradability of fluoxetine HCl, diazepam and their human metabolites in sewage sludge-amended soil. J.Soils Sedim. 2008, 8:217-230.
98. Schering A.G. Growth Inhibition Test with Estradiol (ZK 5018) on the Green Algae Desmodesmus Subspicatus 2002, Report A30506.
99. Schering A.G. Growth Inhibition Test of Ethinylestradiol (ZK4944) on the Green Algae Desmodesmus Subspicatus 2002, Report A12518.
100. Schuetze A., Heberer T., Juergensen S. Occurrence of residues of the veterinary drug malachite green in eels caught downstream from municipal sewage treatment plants. Chemosphere 2008, 72:1664-1670.
101. Schulman L.J., Sargent E.V., Naumann B.D., Faria E.C., Dolan D.G., Wargo J.P. Ahuman health risk assessment of pharmaceuticals in the aquatic environment. Human and ecological risk assessment. Int. J. 2002, 8(4):657-680.
102. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two U.S. Effluent-Impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
103. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-infiammatory drug diclofenac. Part I. Histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68(2):141-150.
104. Schwarzbauer J., Ricking M. Non-target screening analysis of river water as compound-related base for monitoring measures. Environ. Sci. Pollut. Res. 2010, 17:934-947.
105. Shenker M., Harush D., Ben-Ari J., Chefetz B. Uptake of carbamazepine by cucumber plants - a case study related to irrigation with reclaimed wastewater. Chemosphere 2011, 82:905-910.
106. Siemens J., Huschek G., Siebe C., Kaupenjohann M. Concentrations and mobility of human pharmaceuticals in the world's largest wastewater irrigation system, Mexico City-Mezquital Valley. Water Res. 2008, 42:2124-2134.
107. Stülten D., Zühlke S., Lamshöft M., Spiteller M. Occurrence of diclofenac and selected metabolites in sewage effluents. Sci. Total Environ. 2008, 405:310-316.
108. Syracuse Science Center Database of Experimental Octanol-water Partition Coefficients (LogP) 2002, Homepage. http://esc-plaza.syrres.com/interkow/kowdemo.htm.
109. Tan X., Yim S.Y., Uppu P., Kleinow K.M. Enhanced bioaccumulation of dietary contaminants in catfish with exposure to the waterborne surfactant linear alkylbenzene sulfonate. Aquat. Toxicol. 2010, 99:300-308.
110. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 2005, 39:1761-1772.
111. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32(11):3245-3260.
112. Thomann R.V. Bioaccumulation model of organic chemical distribution in aquatic food chains. Environ. Sci. Technol. 1989, 23:699-707.
113. Togunde O.P., Oakes K.D., Servos M.R., Pawliszyn J. Optimization of solid phase microextraction for non-lethal invivo determination of selected pharmaceuticals in fish muscle using liquid chromatography-mass spectrometry. J.Chromatogr. A. 2012, 1261:99-106.
114. Tonnelier A., Coecke S., Zaldivar J.M. Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model. Arch. Toxicol. 2012, 86:393-403.
115. US-EPA EPI Suite, v.4 2008, EPA's office of pollution prevention toxics and Syracuse Research Corporation (SRC).
116. Valenti T.W., Perez-Hurtado P., Kevin Chambliss C.K., Brooks B.W. Aquatic toxicity of sertraline to Pimephales promelas at environmentally relevant surface water pH. Environ. Toxicol. Chem. 2009, 28(12):2685-2694.
117. Vernouillet G., Eullaffroy P., Lajeunesse A., Blaise C., Gagné F., Juneau P. Toxic effects and bioaccumulation of carbamazepine evaluated by biomarkers measured in organisms of different trophic levels. Chemosphere 2010, 80:1062-1068.
118. Wang J., Gardinali P.R. Uptake and depuration of pharmaceuticals in reclaimed water by mosquito fish (Gambusia holbrooki): a worst-case, multiple-exposure scenario. Environ. Toxicol. Chem. 2013, 32(8):1752-1758.
119. Weisbrod A.V., Sahi J., Segner H., James M.O., Nichols J., Schultz I., Erhardt S., Cowan-Ellsberry C., Bonnell M., Hoeger B. The state of invitro science for use in bioaccumulation assessments for fish. Environ. Toxicol. Chem. 2009, 28(1):86-96.
120. Wennmalm A., Gunnarsson B. Pharmaceutical management through environmental product labeling in Sweden. Environ. Int. 2009, 35:775-777.
121. W.H.O Pharmaceuticals in Drinking-water 2012, 52. Technical report. http://www.who.int/water_sanitation_health/publications/2011/pharmaceuticals/en/.
122. Xia K., Bhandari A., Das K., Pillar G. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J.Environ. Qual. 2005, 34:91-104.
123. Yu Y., Wu L. Analysis of endocrine disrupting compounds, pharmaceuticals and personal care products in sewage sludge by gas chromatography-mass spectrometry. Talanta 2012, 89:258-263.
124. Zhang Z.L., Zhou J.L. Simultaneous determination of various pharmaceutical compounds in water by solid-phase extraction-liquid chromatography-tandem mass spectrometry. J.Chromatogr. A 2007, 1154:205-213.
125. Zuccato E., Castiglioni S., Fanelli R. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment. J.Hazard. Mater. 2005, 122(3):205-209.